Try our Advanced Search for more refined results
June 26, 2014
Orexo AB et al v. Actavis Elizabeth LLC
Case Number:
1:14-cv-00829
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
November 22, 2016
Actavis Infringed Orexo's Zubsolv Patent, Del. Judge Rules
A Delaware federal judge has ruled that drugmaker Actavis Elizabeth LLC infringed an Orexo AB patent with its planned generic version of opioid addiction treatment Zubsolv, a ruling Orexo said will keep Actavis from commercializing its product until 2019.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login